However, evidence to the contrary of these results includes: HCC patients with CTNNB1 mutations benefit less from ICI45,46; The activation of CTNNB1 expression can increase the stemness of HCC through lncRNA DANCR47. Here, CTNNB1 is linked to hepatocellular carcinoma.